GENE ONLINE|News &
Opinion
Blog

2026-02-08|

Study Finds Nitazene-Linked Deaths in UK Underreported by 33 Percent

by GOAI
Share To

Research conducted by King’s College London indicates that fatalities linked to synthetic opioids, specifically nitazenes, may be underreported in the United Kingdom by as much as 33%. Published in the journal *Clinical Toxicology*, the study highlights a significant discrepancy between official death statistics and the actual number of deaths involving these substances. The findings come amid a growing surge in synthetic opioid use both within the UK and globally.

Nitazenes are a class of highly potent synthetic opioids, often considered more dangerous than fentanyl due to their increased potency. The study suggests that current methods for tracking drug-related deaths may fail to capture the full extent of fatalities caused by nitazenes. Researchers attribute this underreporting to limitations in toxicology testing and inconsistencies in data collection processes. As synthetic opioid use continues to rise, experts warn that accurate reporting is critical for understanding and addressing this public health issue.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 9, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
Oragenics Submits Annual Report Highlighting Fiscal Year 2025 Financials and Research Updates
2026-03-17
SurgePays Launches Nationwide Campaign to Promote LinkUp Mobile Service
2026-03-17
Tempus and Blood Cancer United Collaborate to Build Extensive Pediatric AML Data Registry
2026-03-17
John Choe Appointed Western Sales Director at Buzz Bomb Caffeine Company
2026-03-17
Two RXO Leaders Earn Fourth Consecutive Recognition in Supply Chain Pros to Know Awards
2026-03-17
Pfizer Reports Phase 2 Trial Success for Atirmociclib in Second-Line Metastatic Breast Cancer Treatment
2026-03-17
Merck to Present Long-Term Efficacy Data on GARDASIL9 and GARDASIL at EUROGIN 2026
2026-03-17
Scroll to Top